Study of the risk factors for severe childhood pertussis based on hospital surveillance data

Vaccine

Volumn 25, Issue 41, 2007, Pages 7224-7232

  Briand, Valérie ^a   Bonmarin, Isabelle ^a   Lévy Bruhl, Daniel ^a  

^a National Institute for Public Health Surveillance   (France)

Author keywords

Children; Pertussis; Vaccination

Indexed keywords

PERTUSSIS VACCINE;

ARTICLE; ASSISTED VENTILATION; CHILD; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; IMMUNOPROPHYLAXIS; INFANT; INFECTION RISK; INFORMATION PROCESSING; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; HOSPITALS; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INFANT; MALE; PERTUSSIS VACCINE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; WHOOPING COUGH;

EID: 34648840505     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.07.020     Document Type: Article

References (19)

1. Baron S., Haeghebaert S., Laurent E., and Guiso N. RENACOQ: surveillance de la coqueluche à l'hôpital en 1998. Bilan de trois années de surveillance. BEH 34 (2000) 143-145
2. Baron S., Njamkepo E., Grimprel E., Begue P., Desenclos J.C., Drucker J., et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: 30 years after a routine use of vaccination. Pediatr Infect Dis J 17 (1998) 412-418
3. Celentano L., Massari M., Paramatti D., Salmaso S., and Eugenio A. Resurgence of pertussis in Europe. Pediatr Infect Dis J 24 9 (2005) 761-765
4. Gilberg S., Njamkepo E., Du Chatelet I.P., Partouche H., Gueirard P., Ghasarossian C., et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J Infect Dis 186 (2002) 415-418
5. Grimprel E., Begue P., Anjak I., Njamkepo E., Francois P., and Guiso N. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France. Clin Diagn Lab Immunol 3 1 (1996) 93-97
6. He Q., Viljanen M.K., Nikkari S., Lyytikainen R., and Mertsola J. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. J Infect Dis 170 (1994) 873-877
7. Gustafsson L., Hessel L., Storsaeter J., and Olin P. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5 and 12 months of age indicates the need for a booster dose at 5-7 years of age. Pediatrics 118 (2006) 978-984
8. Antona D., Bussiere E., Guignon N., Badeyan G., and Levy-Bruhl D. Vaccine coverage of pre-school age children in France in 2000. Euro Surveill 8 6 (2003) 139-144
9. Van Buynder P.G., Owen D., Vurdien J.E., Andrews N.J., Matthews R.C., and Miller E. Bordetella pertussis surveillance in England and Wales: 1995-1997. Epidemiol Infect 123 (1999) 403-411
10. Nielsen N.M., Hedegaard K., and Aaby P. Intensity of exposure and severity of pertussis. J Infect 43 (2001) 177-181
11. Langkamp D.L., and Davis J.P. Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children. J Pediatr 128 5 (1996) 654-659
12. Stojanov S., Liese J., and Belohradsky B.H. Hospitalization and complications in children under 2 years of age with Bordetella pertussis infection. Infection 28 (2000) 106-110
13. Farizo K.M., Cochi S.L., Zell E.R., Brink E.W., Wassilak L.G., and Patriarca P.A. Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis 14 (1992) 708-719
14. Halperin S.A., Wang E.E.L., Law B., Mills E., Morris R., Dery P., et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program-Active (IMPACT). Clin Infect Dis 28 (1999) 1238-1243
15. Gordon M., Davies H.D., and Gold R. Clinical and microbiologic features of children presenting with pertussis to a Canadian pediatric hospital during an 11-year period. Pediatr Infect Dis J 13 (1994) 617-622
16. Juretzko R., von Kries R., Hermann M., Wirsing von Konig C.H., Weil J., and Giani G. Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany. Clin Infect Dis 35 (2002) 162-167
17. Grant C.C., Roberts M., Scragg R., Stewart J., Lennon D., Kivell D., et al. Delayed immunisation and risk of pertussis in infants: unmatched case-control study. BMJ 326 (2003) 852-853
18. Preziosi M.P., and Halloran M.E. Effects of pertussis vaccination on disease: vaccine effectiveness in reducing clinical severity. Clin Infect Dis 37 6 (2003) 772-779
19. Bonmarin I, Laurent E, Guiso N, Gueirard P, Njamkepo E. Renacoq: surveillance de la coqueluche à l'hôpital en 2000. In: Desenclos JC, Vaillant V, Bonmarin I. Surveillance nationale des maladies infectieuses, 1998-2000. Paris, Institut de Veille Sanitaire, 2002:81-4. Available from http://www.invs.sante.fr/publications/2003/snmi/SNMI-F-p079-122.pdf.